Cargando…
Biologicals and small molecules in psoriasis: A systematic review of economic evaluations
Biological therapy for moderate-to-severe psoriasis is highly effective but cost-intensive. This systematic review aimed at analyzing evidence on the cost-effectiveness of biological treatment of moderate-to-severe psoriasis. A literature search was conducted until 30/06/2017 in PubMed, Cochrane Lib...
Autores principales: | Kromer, Christian, Celis, Daniel, Sonntag, Diana, Peitsch, Wiebke K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751984/ https://www.ncbi.nlm.nih.gov/pubmed/29298315 http://dx.doi.org/10.1371/journal.pone.0189765 |
Ejemplares similares
-
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
por: Schaarschmidt, Marthe-Lisa, et al.
Publicado: (2015) -
Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment
por: Kromer, Christian, et al.
Publicado: (2015) -
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
por: Jiang, Yuxiong, et al.
Publicado: (2023) -
Correction: Cost-of-Illness in Psoriasis: Comparing Inpatient and Outpatient Therapy
por: Steinke, Sabine, et al.
Publicado: (2014) -
Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis
por: Caputo, Valerio, et al.
Publicado: (2021)